Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

Suvoda makes Sofia AI assistant available for clinical trials to drive faster answers and action

  • USA - English
  • USA - English
  • USA - Deutsch
  • USA - Français
  • Japan - Japanese
  • USA - español
Suvoda

News provided by

Suvoda LLC

13 Oct, 2026, 23:00 CST

Share this article

Share toX

Share this article

Share toX

Key Takeaways

  • Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails.
  • Sofia helps make complex, fast-moving trial data more accessible to study teams who manage large volumes of time-sensitive work.
  • Study teams can get faster answers and take confident action. Sofia goes beyond information retrieval and can execute authorized system actions on behalf of busy users while maintaining the permissions and audit trails required in clinical trials.

CONSHOHOCKEN, Pa., Oct. 14, 2026 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced that Sofia, its AI assistant on the Suvoda Platform, is ready for all new clinical trials using Suvoda RTSM/IRT or Suvoda eCOA. Sofia gives sponsors, CROs, and sites faster access to trial data and the ability to act on it—through AI built for regulated clinical research.

"Sofia handles the routine operational work so that sponsors, CROs, and sites can focus on the decisions that require their judgment," said E.K. Koh, Chief Product Officer, Suvoda. "We built it with the rigor clinical trials demand because in this environment there is no room for a wrong answer."

Clinical trial teams manage high volumes of time-sensitive work. They track drug inventory, review shipment details, monitor patient visit schedules, and manage questionnaire compliance across global sites. Checking those data streams can pull attention away from patients and judgment-intensive decisions. Sofia is designed to change that equation. The goal is to make complex, fast-moving trial data more accessible so teams can focus their attention where human expertise matters most.

Sofia launched first with early adopter companies that helped shape it before today's expansion to all new Suvoda RTSM/IRT and eCOA trials.

"As an early adopter, we were impressed by how quickly our teams incorporated Sofia into their daily workflow," said Dawn Sorenson, Director, IRT Center of Excellence, Daiichi Sankyo. "The platform's ability to summarize documentation and answer operational questions makes information more accessible and reduces the time spent navigating systems or pulling reports. Tasks that once required multiple steps can now be addressed through a simple conversation, creating meaningful efficiency gains across study operations."

Built differently than general-purpose AI

Some AI tools apply a large language model to a problem and hope the output is accurate. Sofia is built differently. Conversational AI maps each question's intent to Suvoda's validated knowledge space, where subject matter experts have translated expert guidance into validated skills. Those skills execute against live study data within a governed framework that protects the study blind and creates the audit trail clinical trials require. Today, Sofia supports more than 40 topics and is expanding continuously.

From information to action

Sofia does not stop with just answering questions. For authorized users, Sofia can execute system actions on their behalf in a single conversation. Before acting, Sofia summarizes what it will do and asks for confirmation. Every action is attributed to the requesting user, governed by existing roles and permissions, and captured in a full audit trail.

Sofia recently received the PM360 Innovation Award in the Artificial Intelligence category, reflecting the pragmatic yet innovative approach Suvoda took to create Sofia. Early adopters were instrumental to creating a system that really works for what study teams need.

Frequently Asked Questions

Q: How does Sofia handle data privacy and security?
A: Sofia operates with a zero-data retention policy, never uses customer data to train public models, and scopes every user's access to exactly what they are already authorized to see within the Suvoda Platform.

Q: How is Sofia different from a general chatbot?
A: Sofia is a purpose-built, deterministic AI assistant that executes Suvoda-authored expert instructions against live clinical trial data within a governed framework, and it can also take authorized system actions on a user's behalf after obtaining confirmation from the user.

Q: What languages does Sofia support?
A: Sofia responds in the language of the question, supporting global sponsor, CRO, and site teams operating across time zones and regions.

Media Contact:

Robin Abadía

Director, External Communications, Suvoda 

[email protected]

For more Suvoda news, visit our newsroom.

SOURCE Suvoda LLC

Modal title

Also from this source

Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations

Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations

Suvoda, a global clinical trial technology company, today announced a new release of important advancements since unifying the market-leading Suvoda...

Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%

Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%

Getting a clinical trial from contract to go-live can take months. For sponsors working to deliver therapies to patients who need them, the startup...

More Releases From This Source

Explore

Artificial Intelligence

Artificial Intelligence

Computer & Electronics

Computer & Electronics

Data Analytics

Data Analytics

Data Analytics

Data Analytics

News Releases in Similar Topics

Contact PR Newswire

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2026 Cision US Inc.